Bioanalysis
Scope & Guideline
Transforming healthcare through rigorous bioanalysis.
Introduction
Aims and Scopes
- Bioanalytical Method Development:
The journal emphasizes the development of robust and sensitive bioanalytical methods, particularly those utilizing techniques such as LC-MS/MS, HPLC, and immunoassays for quantifying drugs and biomarkers in various biological matrices. - Regulatory Compliance and Guidelines:
Papers often discuss the implications of regulatory guidelines (like ICH M10) on bioanalytical practices, providing insights into best practices for method validation, quality control, and compliance in bioanalytical laboratories. - Emerging Technologies in Bioanalysis:
The journal highlights innovative methodologies such as microsampling, digital PCR, and microfluidics, which aim to enhance the sensitivity, efficiency, and sustainability of bioanalytical assays. - Clinical Applications and Pharmacokinetics:
A core focus is on the application of bioanalytical methods in clinical pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring, with studies addressing the challenges in patient-centric drug assessments. - Biomarker Discovery and Validation:
The journal covers research on the identification and validation of biomarkers for disease diagnosis and treatment monitoring, emphasizing the integration of bioanalytical techniques in biomarker research. - Immunogenicity Assessment:
There is a consistent focus on the assessment of immunogenicity for biotherapeutics, including the development of assays for anti-drug antibodies and their implications for drug efficacy and safety.
Trending and Emerging
- Microsampling Techniques:
Recent publications highlight the increasing use of microsampling techniques, which allow for less invasive sample collection and reduced sample volumes, making them particularly valuable in pediatric and clinical settings. - Integration of Artificial Intelligence and Automation:
There is a growing trend towards incorporating AI and automation in bioanalytical workflows to enhance efficiency, data analysis, and assay development, reflecting broader technological advancements in the field. - Focus on Sustainability in Bioanalysis:
Studies addressing green bioanalytical practices, including eco-friendly sample preparation and solvent use, are emerging, highlighting the industry's commitment to sustainability and environmental impact reduction. - Advancements in Immunogenicity Testing:
The journal has seen an increase in research focusing on the complexities of immunogenicity testing for biologics, emphasizing the need for improved methodologies to assess anti-drug antibodies and their clinical implications. - Multi-Omics Approaches:
There is a notable trend toward multi-omics approaches in bioanalysis, integrating genomics, proteomics, and metabolomics to provide comprehensive insights into drug action and patient response.
Declining or Waning
- Traditional Assays and Techniques:
There appears to be a waning interest in traditional bioanalytical techniques such as standard ELISA and older chromatographic methods, as newer, more sensitive technologies like LC-MS/MS and immunocapture assays gain prominence. - Focus on Single-Analyte Assays:
The journal has seen a decrease in studies focused solely on single-analyte assays, with a trend toward multiplexing and simultaneous quantification methods that provide broader insights into pharmacokinetics and drug interactions. - Methodologies with Limited Clinical Relevance:
Papers focusing on methodologies that lack direct clinical applications or relevance to current therapeutic areas are becoming less common, indicating a shift towards more clinically applicable research.
Similar Journals
BIOPHARM INTERNATIONAL
Pioneering Insights in Biotechnology and PharmaBIOPHARM INTERNATIONAL, published by Advanstar Communications Inc, is a notable journal in the realms of biotechnology and pharmaceutical sciences, with an ISSN of 1542-166X and an E-ISSN of 1939-1862. Since its inception in 2002, the journal has established a platform for the dissemination of innovative research and comprehensive reviews that delve into the intricate interface of biopharmaceutical development and technological advances. Despite its current standing in the Q4 quartile for both Biotechnology and Pharmaceutical Science categories, its commitment to quality and relevance continues to attract contributions from a diverse cadre of researchers and academics. The journal operates within the US, catering to a global audience, and focuses on themes ranging from drug formulation to biotechnological breakthroughs. While the journal currently offers limited Open Access options, it remains a critical resource for those looking to navigate the evolving landscape of pharmaceutical innovations. Researchers, professionals, and students alike will find valuable insights that are essential for staying abreast of key trends and advancements in their fields.
AAPS Journal
Elevating Standards in Pharmaceutical Research and Methodologies.AAPS Journal, published by Springer in the United States, is a leading peer-reviewed journal dedicated to the advancement of research in the field of Pharmaceutical Sciences. With an impressive Q1 rank in its category and a position within the 81st percentile of Scopus rankings, it serves as a vital resource for researchers and professionals seeking to disseminate impactful findings and innovative methodologies. The journal publishes high-quality original research, review articles, and technical reports aimed at addressing the multifaceted challenges in pharmacology, toxicology, and pharmaceutics. Operating under an Open Access model, AAPS Journal ensures broad dissemination of knowledge, contributing to the enhanced visibility and accessibility of research outputs. With a publication window spanning from 1999 to 2024, it continues to shape the future of pharmaceutical research and its applications. Researchers, students, and industry professionals will find a valuable repository of cutting-edge knowledge in this esteemed journal.
Journal of Pharmaceutical and Biomedical Analysis
Advancing knowledge in pharmaceutical and biomedical frontiers.The Journal of Pharmaceutical and Biomedical Analysis, published by ELSEVIER and available in print and online formats, stands as a pivotal source of knowledge in the realms of Analytical Chemistry, Clinical Biochemistry, Drug Discovery, and Pharmaceutical Science. With an ISSN of 0731-7085 and an e-ISSN of 1873-264X, this journal is dedicated to publishing high-quality research that advances the understanding and development of analytical techniques in pharmaceuticals and biomedicine. The journal has earned a solid reputation, reflected in its Q2 category rankings across five distinct fields for 2023, and boasts impressive Scopus rankings, signaling its robust impact within the academic community. The Journal of Pharmaceutical and Biomedical Analysis serves as an essential resource for researchers, professionals, and students alike, providing actionable insights and fostering innovation that can directly influence future advancements in drug development and biomedical applications.
ACTA POLONIAE PHARMACEUTICA
Bridging Academia and Industry in Pharmaceutical ScienceACTA POLONIAE PHARMACEUTICA is a well-established peer-reviewed journal published by Polskie Towarzystwo Farmaceutyczne, dedicated to the field of pharmaceutical sciences and pharmacology. With a rich history dating back to 1951, this journal serves as a vital platform for disseminating cutting-edge research and developments in pharmaceutical technology, drug development, and therapeutic therapies. Although it currently operates under a subscription model, its commitment to scientific rigor has earned it a respectable impact factor, placing it in the Q3 and Q4 quartiles respectively for Pharmaceutical Science and Pharmacology as of 2023. Researchers and practitioners alike will find value in its comprehensive coverage of essential topics, as well as its diverse range of contributions from both established and emerging scholars in the field. With its address located in the heart of Warsaw, Poland, ACTA POLONIAE PHARMACEUTICA aims to further bridge the gap between academia and industry, paving the way for innovation in drug discovery and therapeutic applications.
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
Highlighting Breakthroughs in Chemical SciencesCHEMICAL RESEARCH IN CHINESE UNIVERSITIES is a prominent academic journal dedicated to the dissemination of high-quality research in the field of chemistry and related educational methodologies. Published by HIGHER EDUCATION PRESS, this journal has established itself as a vital resource for researchers and professionals looking to stay at the forefront of chemical sciences. With an impressive impact factor and ranked in the Q2 quartile for both Chemistry and Education categories, it highlights significant advancements while maintaining rigorous peer-review standards. The journal's ISSN is 1005-9040 and its E-ISSN is 2210-3171, ensuring broad accessibility to its global readership. Although it does not offer open access, its contributions are vital to understanding the dynamics of chemistry research and education within and beyond China. With converged publication years from 1999 through to 2024, CHEMICAL RESEARCH IN CHINESE UNIVERSITIES continues to be an essential platform for innovative studies and critical discussions in the expanding realm of chemistry.
BIOMEDICAL CHROMATOGRAPHY
Advancing the Frontiers of Biomedical ResearchBiomedical Chromatography is a prestigious journal published by Wiley, focusing on the vital intersections of analytical chemistry, biochemistry, and clinical studies. With an ISSN of 0269-3879 and E-ISSN of 1099-0801, it has served the research community since its inception in 1986. The journal provides a platform for innovative research in areas such as drug discovery and pharmacology, achieving a commendable placement in Q3 across multiple categories in the 2023 metrics, including Analytical Chemistry and Biochemistry. Although it currently does not offer open access, it plays a crucial role in disseminating scientific developments and methodologies that contribute to advancements in health, safety, and pharmaceuticals. Researchers, professionals, and students can anticipate high-quality, peer-reviewed articles that drive forward the collective knowledge in biomedical applications. Located in the United Kingdom at 111 River St, Hoboken, NJ, the journal continues to attract contributions from global thought leaders in the field.
DRUGS
Advancing Pharmacological FrontiersDRUGS is a prestigious, peer-reviewed journal published by ADIS INT LTD, specializing in the field of pharmacology across diverse medical applications. With an impressive impact factor and ranking as Q1 in the Pharmacology (Medical) category as per the 2023 metrics, this journal consistently exhibits a strong influence in the medical research community, holding a notable rank of #3 out of 272 in its domain on Scopus, placing it within the 99th percentile. Established in 1971 and converging its insightful contributions until 2024, DRUGS encompasses a broad scope, focusing on the latest advancements in drug research, development, and clinical applications, aiming to bridge the gap between laboratory discoveries and therapeutic practices. Though not an Open Access journal, it remains a key resource for researchers, professionals, and students keen on exploring cutting-edge findings and developments in pharmacology. Its location in the United Kingdom further emphasizes its role as a global leader in pharmaceutical sciences.
Analytical and Bioanalytical Chemistry Research
Enhancing Understanding through Open Access Chemistry.Analytical and Bioanalytical Chemistry Research is an esteemed open-access journal published by the Iranian Chemical Society, dedicated to the advancement of knowledge in the fields of analytical chemistry, biochemistry, and spectroscopy. Since its inception in 2014, this journal has provided a platform for researchers, professionals, and students to publish and access high-quality research articles that contribute to the understanding of chemical analysis and bioanalytical methods. With an ISSN of 2383-093X and an open-access model that promotes global dissemination of findings, it ensures that innovative research reaches a broad audience. The journal has consolidated its presence in the scientific community, currently ranked in quartile Q4 for analytical chemistry, biochemistry, and spectroscopy as of 2023. Its Scopus rankings, including a percentile of 34th in Analytical Chemistry, reflect its commitment to quality research and scholarly contribution. Situated in Tehran, Iran, the journal serves as a vital resource for academic discourse, offering insights into emerging trends and methodologies in analytical and bioanalytical chemistry.
LCGC EUROPE
Fostering excellence in analytical methodologies since 1996.LCGC EUROPE is a prominent journal dedicated to the field of analytical chemistry, specifically highlighting the latest trends and innovations in chromatographic techniques. Published by MJH Life Sciences, this journal has served as a valuable resource for researchers, professionals, and students interested in the nuances of laboratory practices and the advancement of instrumentation. Although LCGC EUROPE ceased its coverage in Scopus from 2018, it has maintained a significant influence within the community, evidenced by its Scopus rank of 90/114 in Analytical Chemistry, placing it in the 21st percentile. With its inception dating back to 1996, the journal provided essential insights and peer-reviewed articles, fostering a rich understanding of chromatographic science. While the journal is not currently open access, it remains an integral part of the literature for anyone engaged in the analytical chemistry landscape, especially as it pertains to laboratory methodologies and innovations.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Pioneering Innovative Research in ChemistryANALYTICAL AND BIOANALYTICAL CHEMISTRY, published by SPRINGER HEIDELBERG, is a leading international journal that serves as a vital platform for innovative research in the fields of analytical and bioanalytical chemistry. With an impressive impact factor and ranking in the Q2 category for both Analytical Chemistry and Biochemistry, the journal highlights key advancements and methodologies that drive the discipline forward. Established in 1996 and continuing vigorously into 2024, it has gained significant recognition with Scopus rankings placing it in the 83rd and 78th percentiles within its categories, underscoring its impact and relevance. The journal's commitment to open access facilitates widespread dissemination of critical scientific knowledge, making it an essential resource for researchers, professionals, and students dedicated to exploring the complexities of chemical analysis. With its base in Heidelberg, Germany, ANALYTICAL AND BIOANALYTICAL CHEMISTRY continues to inspire and influence the global research community.